UNSPSC 51352411: Mestranol/norethynodrel

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS200. This VA Drug Class (HS200) classifies this compound as belonging to the group CONTRACEPTIVES, SYSTEMIC.

UNSPSC 51352411 Mestranol/norethynodrel is a Commodity code covering a specific oral contraceptive combination product — a fixed-dose pill containing mestranol (an estrogen) and norethynodrel (a progestin) — that state and local health agencies, school districts, and public health clinics procure through pharmaceutical supply channels. The code tracks a narrow, mature pharmaceutical formulation with established FDA approval and limited innovation scope; most procurement under this code supports public health clinics, correctional health services, family planning programs, and school-based health centers that dispense contraceptives to uninsured or underinsured populations. Issuing bodies are predominantly state health departments, county public health agencies, and municipal health clinics, along with occasional independent school districts with health services operations.

The source provides no recent state and local contract opportunities under this code. Without posted solicitations, bids, or awards in the recent-opportunities record, activity levels and geographic concentration cannot be characterized from current market signals. If your firm is positioned in pharmaceutical supply, distribution, or group purchasing organization partnerships, monitoring this code would require direct outreach to state Medicaid agencies, county health purchasing consortia, and cooperative purchasing vehicles serving public health clinics — the typical buying channels for this formulation — rather than reliance on posted opportunity flow.